AWM
BSX icon

Altium Wealth Management’s Boston Scientific BSX Stock Holding History

Altium Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,163
Closed -$219K – 384
2021
Q4 		$219K Sell
5,163
-3,055
-37% -$128K 0.01% 353
2021
Q3 		$357K Buy
8,218
+654
+9% +$28.9K 0.03% 291
2021
Q2 		$323K Buy
7,564
+1,281
+20% +$53.9K 0.02% 301
2021
Q1 		$243K Buy
+6,283
New +$238K 0.02% 329
2020
Q4 		– Sell
-5,372
Closed -$205K – 354
2020
Q3 		$205K Buy
+5,372
New +$207K 0.02% 313

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Altium Wealth Management's BSX Position: Q1 2022 in Review

Altium Wealth Management sold out of Boston Scientific (BSX) in Q1 2022, closing a stake of 5,163 shares — an estimated $219K sold.

Altium Wealth Management first reported a position in BSX in Q3 2020 and held it in 5 quarters. The position peaked at $357K in Q3 2021. 904 funds tracked by Wall St. Rank hold BSX as of Q1 2022.

  • Altium Wealth Management reported no remaining Boston Scientific position as of Q1 2022 after selling out during the quarter.
  • Altium Wealth Management sold 5,163 Boston Scientific shares in Q1 2022, an estimated $219K.
  • Altium Wealth Management first reported a position in Boston Scientific in Q3 2020 and held it in 5 quarters.
  • Altium Wealth Management's Boston Scientific position peaked at $357K in Q3 2021.
  • 904 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2022.

Based on Altium Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.